Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuo Sonoki

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Diabetes Research and Clinical Practice|September 15, 2009
Relations of lysophosphatidylcholine in low-density lipoprotein with serum lipoprotein-associated phospholipase A2, paraoxonase and homocysteine thiolactonase activities in patients with type 2 diabetes mellitusKazuo Sonoki, Masanori Iwase, Nobuhiro Sasaki, et al.
European Journal of Pharmacology|July 19, 2005
Nateglinide, a non-sulfonylurea rapid insulin secretagogue, increases pancreatic islet blood flow in ratsMasanori Iwase, Udai Nakamura, Yuji Uchizono, et al.
Atherosclerosis|March 14, 2007
Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus: relation with lipoprotein-associated phospholipase A2 and effects of simvastatin treatmentMasanori Iwase, Kazuo Sonoki, Nobuhiro Sasaki, et al.
Journal of Cardiovascular Pharmacology|June 30, 2012
Telmisartan and N-acetylcysteine suppress group V secretory phospholipase A2 expression in TNFα-stimulated human endothelial cells and reduce associated atherogenicityKazuo Sonoki, Masanori Iwase, Shigehiro Ohdo, et al.
Metabolism: Clinical and Experimental|August 30, 2002
Glycoxidized low-density lipoprotein enhances monocyte chemoattractant protein-1 mRNA expression in human umbilical vein endothelial cells: relation to lysophosphatidylcholine contents and inhibition by nitric oxide donorKazuo Sonoki, Mototaka Yoshinari, Masanori Iwase, et al.
Endocrinology|July 12, 2008
Impaired insulin secretion by diphenyleneiodium associated with perturbation of cytosolic Ca2+ dynamics in pancreatic beta-cellsHirofumi Imoto, Nobuhiro Sasaki, Masanori Iwase, et al.
European Journal of Pharmacology|September 5, 2003
Dilazep and fenofibric acid inhibit MCP-1 mRNA expression in glycoxidized LDL-stimulated human endothelial cellsKazuo Sonoki, Masanori Iwase, Kenzo Iino, et al.
Metabolism: Clinical and Experimental|March 21, 2003
Atherogenic role of lysophosphatidylcholine in low-density lipoprotein modified by phospholipase A2 and in diabetic patients: protection by nitric oxide donorKazuo Sonoki, Masanori Iwase, Kenzo Iino, et al.
Free Radical Biology & Medicine|May 24, 2006
Rapid intracellular acidification and cell death by H2O2 and alloxan in pancreatic beta cellsUdai Nakamura, Masanori Iwase, Yuji Uchizono, et al.
Endocrine Journal|November 10, 2012
Effects of thirty-times chewing per bite on secretion of glucagon-like peptide-1 in healthy volunteers and type 2 diabetic patientsKazuo Sonoki, Masanori Iwase, Yutaka Takata, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Diabetes Research and Clinical Practice|September 15, 2009
Relations of lysophosphatidylcholine in low-density lipoprotein with serum lipoprotein-associated phospholipase A2, paraoxonase and homocysteine thiolactonase activities in patients with type 2 diabetes mellitusKazuo Sonoki, Masanori Iwase, Nobuhiro Sasaki, et al.
European Journal of Pharmacology|July 19, 2005
Nateglinide, a non-sulfonylurea rapid insulin secretagogue, increases pancreatic islet blood flow in ratsMasanori Iwase, Udai Nakamura, Yuji Uchizono, et al.
Atherosclerosis|March 14, 2007
Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus: relation with lipoprotein-associated phospholipase A2 and effects of simvastatin treatmentMasanori Iwase, Kazuo Sonoki, Nobuhiro Sasaki, et al.
Journal of Cardiovascular Pharmacology|June 30, 2012
Telmisartan and N-acetylcysteine suppress group V secretory phospholipase A2 expression in TNFα-stimulated human endothelial cells and reduce associated atherogenicityKazuo Sonoki, Masanori Iwase, Shigehiro Ohdo, et al.
Metabolism: Clinical and Experimental|August 30, 2002
Glycoxidized low-density lipoprotein enhances monocyte chemoattractant protein-1 mRNA expression in human umbilical vein endothelial cells: relation to lysophosphatidylcholine contents and inhibition by nitric oxide donorKazuo Sonoki, Mototaka Yoshinari, Masanori Iwase, et al.
Endocrinology|July 12, 2008
Impaired insulin secretion by diphenyleneiodium associated with perturbation of cytosolic Ca2+ dynamics in pancreatic beta-cellsHirofumi Imoto, Nobuhiro Sasaki, Masanori Iwase, et al.
European Journal of Pharmacology|September 5, 2003
Dilazep and fenofibric acid inhibit MCP-1 mRNA expression in glycoxidized LDL-stimulated human endothelial cellsKazuo Sonoki, Masanori Iwase, Kenzo Iino, et al.
Metabolism: Clinical and Experimental|March 21, 2003
Atherogenic role of lysophosphatidylcholine in low-density lipoprotein modified by phospholipase A2 and in diabetic patients: protection by nitric oxide donorKazuo Sonoki, Masanori Iwase, Kenzo Iino, et al.
Free Radical Biology & Medicine|May 24, 2006
Rapid intracellular acidification and cell death by H2O2 and alloxan in pancreatic beta cellsUdai Nakamura, Masanori Iwase, Yuji Uchizono, et al.
Endocrine Journal|November 10, 2012
Effects of thirty-times chewing per bite on secretion of glucagon-like peptide-1 in healthy volunteers and type 2 diabetic patientsKazuo Sonoki, Masanori Iwase, Yutaka Takata, et al.
Pageof 6